Asia~Pacific Portfolio Strategy: Asian equity market daily update
Goldman Sachs· 2024-08-14 02:49
13 August 2024 | 8:31 PM SGT Asia-Pacific Portfolio Strategy: Asian equity market daily update: The MXAPJ Index was flat today. Indonesia and Philippines markets outperformed, while India and Australia markets underperformed. Within MXAPJ sectors, Info Tech and Comm Serv led while Health Care and Materials lagged. MSCI Japan rose 3.1% today. For a detailed analysis, please see Weathering summer storms, August 7, 2024. Exhibit 1: The MXAPJ index has gained 5.2% YTD after gaining 5% in 2023, particularly led ...
Amotiv Ltd. (AOV.US): FY24 First Take: Result in~line with May guidance; Buy
Goldman Sachs· 2024-08-14 02:49
14 August 2024 | 8:53AM AEST Amotiv Ltd. (AOV.AX): FY24 First Take: Result in-line with May guidance; Buy Amotiv (AOV) have reported their FY24 results, the first under their new name and new segmentation. GS take: Result largely in-line with expectations with minimal specific guidance provided. Buy. Key takeaways: ■ Group Ebita of A$194.6m marginally above May guidance of 'at least A$193.5m'. APG achieved Ebita of A$63.1m (May guidance of A$63m). Performance in Lighting (+7.3% organic; +13.3% with acquisit ...
Allos SA (ALOS3.SA)2Q24 First Take:Improving Fundamentals; Income Statement Within Expectations
Goldman Sachs· 2024-08-14 02:49
13 August 2024 | 10:10PM BRT Allos SA (ALOS3.SA): 2024 First Take:Improving Fundamentals; Income Statement Within Expectations Jorel Guilloty +55(11)3372-3522 jorel.quilloty@as.com Goldman Sachs do Brasil CTVM S.A. Our take: We expect Allos 2024 results to have a muted impact on shares. Net revenue and NOI came within expectations, while property EBITDA and FFO came slightly ahead driven by better SG&A. Fundamentals generally saw an improvement with occupancy rising 60 bps y/y to 96.3%. Occupancy cost saw a ...
Americas Healthcare:Biotechnology,Boston Biotech Bus Tour~Day 1 takeaways
Goldman Sachs· 2024-08-14 02:49
13 August 2024 | 5:49AM EDT Americas Healthcare: Biotechnology: Boston Biotech Bus Tour - Day 1 takeaways We met with the management teams from LNTH, BPMC, KYMR, and RYTM during Day 1 of our Boston biotechnology bus tour. We offer our detailed takeaways below. Takeaways Lantheus Holdings (LNTH, Not Covered) We hosted Brian Markison (CEO), Paul Blanchfield (President), and Robert Marshall (CFO), as well as representatives of the company's investor relations team during our 2024 Boston Biotech Bus Tour. The c ...
Americas Restaurants: SBUX appoints current CEO of CMG as new Chairman/CEO
Goldman Sachs· 2024-08-14 02:49
13 August 2024 | 9:27AM EDT Americas Restaurants: SBUX appoints current CEO of CMG as new Chairman/CEO This morning, SBUX announced that Brian Niccol has been appointed chairman and chief executive officer, with the current CEO/chairman Laxman Narasimhan stepping down effective immediately. Mr. Niccol will join the company on September 9, with current CFO Rachel Ruggeri serving as interim CEO until then. CMG's Board of Directors has appointed Scott Boatwright, Chief Operating Officer, as Interim CEO. SBUX: ...
Americas Energy Key learnings from earnings season that support The Future of Utilities Capex; Buy SRE, PWR
Goldman Sachs· 2024-08-14 02:48
13 August 2024 | 7:45PM EDT Americas Energy Key learnings from earnings season that support The Future of Utilities Capex; Buy SRE, PWR The Future of Utilities Capex Explore > With second quarter earnings season now behind us, we reflect on key learnings that support The Future of Utilities Capex, our constructive view on Utilities, and our Buy rating on Quanta Services (PWR). We believe commentary from utilities continues to point to positive capital spending revisions as we look to the Fall and early 2025 ...
Americas Agriculture: Proposed changes in LCFS
Goldman Sachs· 2024-08-14 02:48
13 August 2024 | 11:07AM EDT Americas Agriculture: Proposed changes in LCFS Late Monday (8/12), the California Air Resources Board (CARB) proposed amendments to the Low Carbon Fuel Standard (LCFS), subject to a public hearing & vote on November 8th. This follows prior proposal amendments issued in December 2023 that had been scheduled for hearing & vote in February 2024 that was ultimately postponed. Key highlights of proposed changes 1) 9% step-down in 2025 CI reduction. CARB is proposing to modify the nea ...
FIT Hon Teng (6088.HK) 2Q24 in~line; Upbeat guidance on power busbar and liquid cooling order wins
CMB International· 2024-08-14 02:37
14 Aug 2024 CMB International Global Markets | Equity Research | Company Update FIT Hon Teng (6088 HK) 2Q24 in-line; Upbeat guidance on power busbar and liquid cooling order wins FIT Hon Teng posted a strong set of 2Q24 results, in-line with prior positive profit alert. Following our NDR call with mgmt., we are constructive on rapid expansion of Al server product portfolio: 1) power busbar and liquid cooling CDU products certified by customers (1-3% of FY24E sales), 2) sampling of backplane connector soluti ...
TME (TME.US) Inline 2Q24 results; focus on balanced growth of music subs and ARPPU in 2H24E
CMB International· 2024-08-14 01:09
14 Aug 2024 CMB International Global Markets | Equity Research | Company Update TME (TME US) Inline 2Q24 results; focus on balanced growth of music subs and ARPPU in 2H24E TME announced 2Q24 results on 13 Aug: total revenue declined by 2% YoY to RMB7.16bn, in line with our/Bloomberg consensus estimate of RMB7.16/7.13bn; non-IFRS net income was up by 22% YoY to RMB1.87bn, 2/2% ahead of our/consensus estimate. For 2H24E, management will focus more on balanced growth of music subs and ARPPU, expecting slower m ...
Q~Tech (1478.HK)1H24 earnings recovery on fast track; reiterate BUY
CMB International· 2024-08-14 01:07
13 Aug 2024 CMB International Global Markets | Equity Research | Company Update Q-Tech (1478 HK) 1H24 earnings recovery on fast track; reiterate BUY Q-tech announced in-line 1H24 results driven by strong CCM/FPM growth and GPM improvement on smartphone demand rebound, share gains, an increasing UTR and a better high-end product mix. For 2H24/2025, we remain positive on high-end spec upgrade to drive ASP/GPM, auto CCM sales growth to accelerate under rising NEV penetration and ultra-sound FPM upgrade in smar ...